Added to YB: 2016-09-22
Pitch date: 2016-09-22
OCUL:US [bullish]
Ocular Therapeutix, Inc.
+56.57%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
Market Cap
$1.9B
Pitch Price
$4.49
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.86
P/E
-6.25
EV/Sales
24.50
Sector
Pharmaceuticals
Category
N/A
Show full summary:
OCULAR THERAPEUTIX INC COM OCUL:US
A summary for this pitch has not been created yet.
Read full article (0 min)